It is also interesting to me that, you know, while we have H.R. 3 out there, which is, again, an attempt to kind of take over this from a government standpoint, we have another option out there, H.R. 19, which does address pay for delay, product hyping, patent evergreening, which are serious issues that need to be dealt with.
Editor's note · Context
Discussing legislative options for addressing drug pricing issues.
Share & report
More from Mike Cloud
I do find it odd that part of the communication was scheduling the communication and the concern that the union and the Biden Administration might stand apart from a messaging standpoint.
I think it is about time that we get back to talking about what happened because vaccine hesitancy is an issue.
Madam Speaker, I move that the House do now adjourn. The motion was agreed to; accordingly (at 8 o'clock and 6 minutes p.m.), under its previous order, the House adjourned until tomorrow, Thursday, December 14, 2023, at 9 a.m…
Mr. Chair, my amendment makes a technical fix to what seems to be a copy and paste drafting error in the bill, replacing ``Treasure Island Job Corps'' in section 114 of the bill, which was the language signed into last year's bill, to…





